GLP-1 Benefits Beyond Weight Loss: What Recent Studies Are Showing

I believe GLP-1s are about so much more than weight loss.

I have for a while, and the more I read and experience for myself, the more convinced I am that we’re only beginning to understand what these medications can do for the body as a whole.

That’s why I’m so excited to walk you through what the recent studies are showing. The research is moving quickly, and there’s a lot to be encouraged about.

Nothing here is a promise, and none of it means a medication is approved or cleared for these uses. These are study findings, and many are still early, but they point in a promising direction.

What Doctors Are Saying

I’m not the only one who feels this way. Some well-respected physicians are talking about it too.

• Dr. Harlan Krumholz, a cardiologist at the Yale School of Medicine, has called these “generational breakthrough medications” and points to benefits ranging from lower cardiovascular risk to sleep apnea and chronic kidney disease
• Dr. Natalie Azar has said that weight loss alone doesn’t fully explain what’s being seen, and that GLP-1s likely work by targeting inflammation
• Dr. Mark Jabro, an obesity medicine specialist, says GLP-1s “aren’t just appetite suppressants,” and describes effects on the brain’s hunger and reward circuits along with real health benefits beyond weight

The Short Version

• Stronger evidence: heart health, sleep apnea, cravings and appetite
• Promising but still developing: inflammation, liver and kidney health, joint pain, cancer risk
• Early or small studies: skin conditions, substance use, asthma, muscle preservation
• Didn’t pan out (so far): Alzheimer’s disease
• Too early to say: anti-aging and fertility

Stronger Evidence

Heart health

This is the area that first made me think the story was bigger than the scale. Krumholz has even described the whole class as a “heart drug,” and the research keeps pointing that way.

• One recent review reported reductions in cardiovascular events, citing figures between 14% and 20% depending on the analysis
• It also noted improvements in heart failure outcomes
• The benefit appeared regardless of diabetes status

Sleep apnea

Because excess weight can affect breathing during sleep, this finding makes sense to many clinicians, and it matters for how people feel every day.

• Studies have found GLP-1s significantly reduce the severity of obstructive sleep apnea
• Better sleep may also mean less daytime fatigue, which is one more reason this finding stands out

Cravings and appetite

This is often the effect people notice first, and it has real life experience and research behind it.

• Clinical trials have consistently shown less hunger and fewer intrusive food thoughts
• Smaller brain imaging studies found less activity in reward-related brain regions when people saw high-calorie foods
• A peer-reviewed review found reduced binge-eating frequency, while also noting that rapid medication-driven weight loss can affect body image and needs thoughtful support

Promising, But Still Developing

Inflammation and organ health

Inflammation keeps surfacing as a possible thread connecting many of these findings.

• A CU Anschutz editorial reviewing six studies suggests benefits for the heart, kidneys, and liver may occur even in people who lose little or no weight
• Researchers believe additional mechanisms, such as anti-inflammatory effects, likely play a role
• Jabro notes these medications appear to lower inflammation partly through weight loss and partly through direct effects on the body
• More research is needed to understand exactly how this works

Liver health

Fatty liver disease is one of the areas I’m following most closely, and one recent finding stood out.

• A study published this April found substantial liver benefits even when weight loss was blocked in mice
• That hints some effects may not depend on weight loss alone
• Animal findings don’t always carry over to people, so this is a lead, not a conclusion

Joint pain

Knee osteoarthritis has been a big focus of recent presentations, and to me it’s a perfect example of why inflammation may be part of the picture.

• At the American Diabetes Association’s 2026 Scientific Sessions, researchers discussed a trial in which knee osteoarthritis patients had larger pain score reductions than a comparison group, along with less use of pain medication
• In a separate trial, roughly 23% weight loss produced pain relief similar to what was seen with 13% weight loss, so researchers suspect it isn’t only about less pressure on the joints

Cancer risk

These are the headlines you’ve probably seen, and they’re the ones I most want you to read carefully.

• A 2026 study linked GLP-1 use to a 41% lower risk of obesity-related cancers in non-diabetic patients using the drugs for weight loss
• Research presented at ASCO 2026 suggested women with excess weight who used GLP-1s were about 30% less likely to develop breast cancer
• These are observational studies, which show patterns but can’t prove cause and effect
• Researchers describe them as a reason to keep investigating, not a conclusion

Early and Small Studies

Some areas have only limited evidence so far, but they’re a big part of why I’m so curious about where this goes.

• Small studies have found GLP-1s could help improve kidney function, psoriasis, and fat around the heart
• Researchers are studying whether these medications can help with addiction, including smoking cessation, and a meta-analysis on the topic was published this summer
• One study reported GLP-1 use was consistently associated with lower risks of developing substance use disorders, and early research suggests a possible link to fewer asthma attacks, as covered by TODAY
• Weight loss on these medications typically includes some muscle loss, and researchers are actively studying ways to preserve it, with exercise and protein remaining the cornerstones

Where the Hype Got Ahead of the Evidence

Believing in something means being willing to look at the parts that didn’t work out, so here they are.

• Alzheimer’s disease: Earlier data suggested a lower risk, but in two large phase 3 trials, a GLP-1 medication did not slow disease progression compared with placebo, even though some related biomarkers improved
• Fertility: Ideas about improving egg and sperm quality independent of weight loss are still theoretical

Why I’m Very Optimistic

When I look at all of this together, what stands out to me is how many body systems keep showing up in the research: the heart, the liver, the joints, sleep, inflammation, even appetite and cravings.

To me, that’s what makes GLP-1s so worth paying attention to.

Optimism isn’t a guarantee, though.

• Results vary from person to person
• Side effects are possible
• These medications aren’t right for everyone
• Cost, supply, and insurance coverage still limit who can access them
• The best starting point is a conversation about your health history and goals with a licensed provider

If you’re curious whether a GLP-1 might fit into your plan, we’d love to talk it through. You can learn more about medical weight loss with GLP-1s in Parker, CO, or book a consultation and we’ll start with your health history and goals.

— Crystal Harmon, Owner, Laguna Med Spa

This article is for educational purposes only and is not medical advice. GLP-1 medications are prescribed based on individual evaluation by a licensed provider, and some uses discussed in research are not FDA-approved.